![David Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Perry
Fondateur chez
Better Therapeutics LLC
Profil
David P.
Perry is the founder.
He founded Ventro Corp.
in 1997 and served as the Chief Executive Officer in 2001.
He also founded Anacor Pharmaceuticals LLC in 2002 and held the positions of President, Chief Executive Officer & Director until 2014.
In 2015, Mr. Perry founded Better Therapeutics, Inc. and served as the Executive Chairman.
Mr. Perry is also the founder of Better Therapeutics LLC.
Currently, Mr. Perry holds the position of Director at the Infectious Disease Research Institute and Director at the A.P.
Giannini Foundation.
Mr. Perry's former positions include being the President, Chief Executive Officer & Director at Indigo Ag, Inc. from 2015 to 2020, Vice Chairman at NexPrise, Inc., Independent Director at Evelo Biosciences, Inc. from 2016 to 2022, Manager at Exxon Corp., and Principal at Small Business Development Group, Inc. In terms of education, Mr. Perry completed his undergraduate degree at The University of Tulsa and obtained an MBA from Harvard Business School.
Postes actifs de David Perry
| Sociétés | Poste | Début |
|---|---|---|
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Directeur/Membre du Conseil | 13/09/2010 |
A.P. Giannini Foundation | Directeur/Membre du Conseil | - |
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Fondateur | - |
Anciens postes connus de David Perry
| Sociétés | Poste | Fin |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Fondateur | 14/03/2024 |
| EVELO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 09/06/2022 |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Directeur Général | 02/09/2020 |
| ANACOR PHARMACEUTICALS INC | Fondateur | 18/03/2014 |
Ventro Corp.
 Ventro Corp. Information Technology ServicesTechnology Services Provides e-commerce solutions. | Directeur Général | 01/01/2001 |
Formation de David Perry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Exxon Corp.
 Exxon Corp. Oil Refining/MarketingEnergy Minerals Operates petroleum refineries | Energy Minerals |
Ventro Corp.
Ventro Corp. Information Technology ServicesTechnology Services Provides e-commerce solutions. | Technology Services |
Small Business Development Group, Inc.
 Small Business Development Group, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
NexPrise, Inc.
 NexPrise, Inc. Miscellaneous Commercial ServicesCommercial Services Provides process applications and market solutions | Commercial Services |
The University of Tulsa
 The University of Tulsa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Health Technology |
A.P. Giannini Foundation | |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Better Therapeutics LLC
Better Therapeutics LLC Medical SpecialtiesHealth Technology Develops digital therapeutics for treating cardio-metabolic diseases | Health Technology |
Better Therapeutics, Inc.
 Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
